The Medicines Act of 1968 is a piece of legislation in the United Kingdom that regulates the manufacture and sale of medicinal products. The act was introduced to ensure the safety, quality and efficacy of medicines available to the public. It provides a framework for the licensing and distribution of medicines.
The top 5 fines amount to nearly $9 billion, contributing to a collective fine tally of $40 billion over the last 10 years.
Don't wait until it's too late, Schedule your material compliance discussion today!
To address the substantial financial challenges, the pharmaceutical industry is progressively embracing innovative solutions such as Congrego to proactively minimize these significant fines, potentially resulting in saving millions, if not billions of dollars.
Congrego enables precise control over medical product promotion, preventing off-label usage. It allows remote management of internal and external material compliance, ensures proper distribution, and automatically withdraws outdated or non-approved content.
Gain confidence in material accuracy, track document understanding, and enjoy seamless compliance with leading pharmaceutical companies.
Congrego is comprised of two elements, the web app and the .net content management system. Each instance is hosted on a private AWS server with user accounts management by industry leading AWS Cognito.
All aspects of Congrego have been rigorously checked to ensure compliance with the pharmaceutical industry, data and privacy requirements.
Congrego is fully approved and in use by leading pharmaceutical companies
References:
1. Violation Tracker https://violationtracker.goodjobsfirst.org/pages/violation-tracker-data-sources